Brainstorm Cell Therapeu... News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Brainstorm Cell Therapeutics Inc BCLI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.09 2.27% 4.06 19:47:52
Open Price Low Price High Price Close Price Prev Close
4.01 3.91 4.16 4.06 3.97
more quote information »

Recent News

Date Time Source Heading
2/22/202108:47SEEKBrainStorm shares plunge 25% after FDA feedback on NurOwn..
2/02/202115:16EDGARStatement of Ownership (sc 13g)
11/19/202018:01EDGARStatement of Changes in Beneficial Ownership (4)
11/17/202008:01EDGARCurrent Report Filing (8-k)
11/12/202007:01EDGARCurrent Report Filing (8-k)
10/27/202006:05EDGARCurrent Report Filing (8-k)
10/01/202016:53EDGARProxy Statement (definitive) (def 14a)
9/25/202016:16EDGARCurrent Report Filing (8-k)
9/25/202016:15EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/16/202007:30PRNUSBrainstorm Announces Grant of a New Japanese Patent for..
9/10/202016:08EDGARStatement of Changes in Beneficial Ownership (4)
9/03/202016:06EDGARCurrent Report Filing (8-k)
8/10/202006:07EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
8/05/202007:01EDGARQuarterly Report (10-q)
8/05/202007:00PRNUSBrainStorm Announces Financial Results for the Second..
7/31/202017:11EDGARStatement of Changes in Beneficial Ownership (4)
7/27/202007:58PRNUSBrainStorm Cell Therapeutics to Announce Second Quarter..
7/23/202007:00GLOBEBrainStorm Announces Groundbreaking Pre-Clinical Study of..
7/16/202017:16EDGARStatement of Changes in Beneficial Ownership (4)
7/16/202017:10EDGARStatement of Changes in Beneficial Ownership (4)
7/16/202017:05EDGARStatement of Changes in Beneficial Ownership (4)
7/08/202005:31PRNUSBrainStorm Hosting KOL Webinar to Discuss NurOwn® Phase 2..
7/02/202006:49PRNUSBrainStorm Announces Completion of All Dosing in NurOwn®..
7/01/202008:50PRNUSBrainStorm to Showcase Alzheimer's Disease Clinical Program..
6/26/202017:02EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
6/26/202017:01EDGARStatement of Changes in Beneficial Ownership (4)
6/26/202017:01EDGARCurrent Report Filing (8-k)
6/24/202007:00PRNUSBrainStorm Expands Clinical Pipeline to Evaluate NurOwn® for..
6/15/202009:00GLOBEBrainStorm Granted SME Status by the European Medicines..
6/11/202007:28PRNUSBrainStorm to Present at the Raymond James Human Health..
6/09/202006:00PRNUSThe ALS Association, I AM ALS Award BrainStorm Cell..
6/03/202006:00PRNUSBrainStorm to Participate in BIO Digital 2020
6/02/202006:00PRNUSBrainStorm Announces that Pivotal Phase 3 Trial Remains on..
6/01/202017:35EDGARInitial Statement of Beneficial Ownership (3)
6/01/202017:35EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202007:25PRNUSBrainStorm Appoints Pharmaceutical Veteran Stacy R...
5/08/202012:05EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
5/07/202006:32EDGARQuarterly Report (10-q)
5/07/202006:30GLOBEBrainStorm Announces Financial Results for the First Quarter..
5/07/202001:00GLOBEBrainStorm Leases a New Cleanroom Facility at The Tel Aviv..
5/04/202003:30GLOBEBrainStorm Presents New Data Highlighting NurOwn®..
4/29/202006:00GLOBEBrainStorm-Cell Therapeutics to Announce First Quarter..
4/08/202006:03EDGARStatement of Beneficial Ownership (sc 13d)
4/07/202018:17EDGARStatement of Changes in Beneficial Ownership (4)
4/07/202018:16EDGARInitial Statement of Beneficial Ownership (3)
4/07/202018:15EDGARStatement of Changes in Beneficial Ownership (4)
4/07/202018:14EDGARInitial Statement of Beneficial Ownership (3)
4/07/202018:12EDGARStatement of Changes in Beneficial Ownership (4)
4/07/202018:12EDGARInitial Statement of Beneficial Ownership (3)
4/03/202017:01EDGARCurrent Report Filing (8-k)
See more news about this stock »

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.